1. Home
  2. THRY vs VYGR Comparison

THRY vs VYGR Comparison

Compare THRY & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

BUY

Current Price

$1.15

Market Cap

179.6M

Sector

Industrials

ML Signal

BUY

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

BUY

Current Price

$2.08

Market Cap

193.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
THRY
VYGR
Founded
2012
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.6M
193.5M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
THRY
VYGR
Price
$1.15
$2.08
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
$4.00
★ $14.89
AVG Volume (30 Days)
541.4K
★ 739.1K
Earning Date
10-29-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 100.50
N/A
EPS
★ N/A
N/A
Revenue
★ $785,015,000.00
$10,135,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$129.75
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.18
$1.89
52 Week High
$12.57
$5.19

Technical Indicators

Market Signals
Indicator
THRY
VYGR
Relative Strength Index (RSI) 21.60 25.01
Support Level N/A N/A
Resistance Level $4.22 $4.29
Average True Range (ATR) 0.09 0.13
MACD -0.01 -0.04
Stochastic Oscillator 3.12 12.72

Price Performance

Historical Comparison
THRY
VYGR

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: